These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 8731525

  • 1. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy").
    Cohen RS.
    Biol Psychiatry; 1996 May 01; 39(9):819-20. PubMed ID: 8731525
    [No Abstract] [Full Text] [Related]

  • 2. [Psychiatric disorders and consumption of ecstasy drug (MDMA): review of published case reports].
    Bango J, Fadón P, Mata F, Rubio G, Santo-Domingo J.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1998 May 01; 26(4):260-3. PubMed ID: 9807860
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ecstasy (MDMA) and memory function: a meta-analytic update.
    Laws KR, Kokkalis J.
    Hum Psychopharmacol; 2007 Aug 01; 22(6):381-8. PubMed ID: 17621368
    [Abstract] [Full Text] [Related]

  • 8. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul 01; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 9. Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use.
    Gouzoulis-Mayfrank E, Fischermann T, Rezk M, Thimm B, Hensen G, Daumann J.
    Drug Alcohol Depend; 2005 Jun 01; 78(3):317-23. PubMed ID: 15893163
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [MDMA--"ecstasy"].
    Keup W.
    Med Monatsschr Pharm; 1996 Jan 01; 19(1):2-5. PubMed ID: 8583979
    [No Abstract] [Full Text] [Related]

  • 13. Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users.
    Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan T, Scholey AB.
    Hum Psychopharmacol; 2006 Jul 01; 21(5):285-98. PubMed ID: 16856221
    [Abstract] [Full Text] [Related]

  • 14. Ecstasy (MDMA) and oral health.
    Brand HS, Dun SN, Nieuw Amerongen AV.
    Br Dent J; 2008 Jan 26; 204(2):77-81. PubMed ID: 18268544
    [Abstract] [Full Text] [Related]

  • 15. The dark side of ecstasy: neuropsychiatric symptoms after exposure to 3,4-methylenedioxymethamphetamine.
    Karlsen SN, Spigset O, Slørdal L.
    Basic Clin Pharmacol Toxicol; 2008 Jan 26; 102(1):15-24. PubMed ID: 18047478
    [Abstract] [Full Text] [Related]

  • 16. What is a dose of ecstasy?
    Cole JC, Sumnall HR, Wagstaff GF.
    J Psychopharmacol; 2002 Jun 26; 16(2):189-90. PubMed ID: 12095080
    [No Abstract] [Full Text] [Related]

  • 17. Recreational ecstasy use and depression.
    Guillot C, Greenway D.
    J Psychopharmacol; 2006 May 26; 20(3):411-6. PubMed ID: 16574715
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Comment on R. Thomasius, M. Schmolke, D. Kraus: MDMA ("Ecstasy") use--an overview of psychiatric and medical sequelae].
    Gouzoulis-Mayfrank E, Hermle L, Kovar KA, Sass H.
    Fortschr Neurol Psychiatr; 1999 Dec 26; 67(12):574-6. PubMed ID: 10683753
    [No Abstract] [Full Text] [Related]

  • 20. Major depression: the relative contribution of gender, MDMA, and cannabis use.
    Durdle H, Lundahl LH, Johanson CE, Tancer M.
    Depress Anxiety; 2008 Dec 26; 25(3):241-7. PubMed ID: 17345601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.